-
We have published an updated version of the Frequently Asked Questions to 'Special Mail 5: Guidance on the submission of applications to the MHRA'. This document should be read in conjunction with 'Special Mail 5', which defines a standard approach to sending submissions for medicines to the MHRA.
-
-
Our Christmas and New Year opening times.
-
The outcome of an investigation into a complaint about the advertising of medicines has been published.
-
It came to our attention that an advertisement for Metoject produced by Medac UK claimed that Metoject was the ‘the only officially licensed MTX injection’. The case was upheld.
-
Minutes of the Ministerial Industry Strategy Group (MISG) New Technologies Advisory Panel.
-
This news sheet aimed at laboratory staff, details some of the device problems that have been reported to us which relate to the use IVDs or their results.
-
We have been informed that there is the possibility of delivering an unintended 1.7 ml bolus if the pump door is opened and then immediately closed following a stoppage of the pump.
-
We have issued a press release warning of the dangers of four unlicensed Traditional Herbal products, Xiao Qin Long Wan, Chuan Xiong Cha Tiao Wan, Bai Tou Weng Wan and Xie Gan Wan, reported to contain aristolochic acids that have been found on the UK market.
-
This, the final issue of our updating journal for medicines, includes articles on the Paediatric Regulation, Risk Management Plans, and guidance on the submission of Decentralised and Centralised Procedure applications.